INDEX| CONTACT US Read the interview >> Read our 2014 Foundation & CSR Report >> Our Company | R&D | Products | News | Investors | Partnering | Responsibility | Careers Bristol-Myers Squibb Researchers Receive a 2014 PhRMA Research and Hope Award Read more >> Watch video highlighting our honored researchers >> LATEST NEWS September 29, 2014 European Medicines Agency Validates the Marketing Authorization Application for Nivolumab in Non-Small Cell Lung Cancer September 29, 2014 Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy (ipilimumab) Presented at the ESMO 2014 Congress; First Phase 3 Results Presented for a PD-1 Immune Checkpoint Inhibitor September 26, 2014 Bristol-Myers Squibb Announces Multiple Regulatory Milestones for Opdivo (nivolumab) in the U.S. and European Union Get RSS News Alerts Follow us on twitter.com/bmsnews June 30, 2014 COUMADIN® (warfarin sodium) FOR INJECTION Recall Information 5 mg single-use vials Clinical Trials and Research Learn about Bristol-Myers Squibb's Clinical Trial Activities and Investigator-Sponsored Research Interactions with Health Care Professionals Learn more about our commitment to transparency related to our collaborations with physicians, researchers and other health care professionals. Health Care Professionals Access medical information and resources Need Help Paying for Your Bristol-Myers Squibb Medicines? Learn about our assistance programs. Patients and Caregivers Learn about clinical trial participation at Bristol-Myers Squibb Study Connect California Transparency in Supply Chains (PDF) © 2014 Bristol-Myers Squibb Company Legal Notice » Privacy Policy » Trademarks